Anti-p40(IL-12/IL-23) monoclonal Antibody (Wezlana Biosimilar)
Figure 1: Coomassie staining of SDS-PAGE gel loaded with Wezlana biosimilar mAb (Abeomics Cat# 12-9612) at 2 µg, 5 µg, 10 µg at reducing condition and 5 µg under non-reducing conditions.
Roll over image to zoom in
Shipping Info:
Order now and get it on Wednesday December 25, 2024
Same day delivery FREE on San Diego area orders placed by 1.00 PM
| Amount : | 100 µg |
| Isotype : | IgG1,k |
| Content : | Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Reconstitute in sterile water. |
| Storage condition : | Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized antibodies are shipped at ambient temperature. |
| Alternative Name : | Wezlana, west, Ustekinumab-auub |
Wezlana (Ustekinumab-auub) is a biosimilar to Stelera. The U.S. Food and Drug Administration approved Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara (ustekinumab) for multiple inflammatory diseases. Ustekinumab is a fully human IgG1 monoclonal antibody that binds with specificity to the shared p40 protein subunit of human cytokines interleukin IL-12 and IL-23, which are involved in immune and inflammatory responses. IL-12 and IL-23 are produced by activated antigen-presenting cells as secreted heterodimeric cytokines that bind to receptor complexes in natural killer cells and T cells. Ustekinumab can effectively neutralizing both human IL-12 (Th1)-mediated and IL-23 (Th17)-mediated cellular responses.
FACS 1:100
For Research Use Only. Not for use in diagnostic/therapeutics procedures.
|
There are currently no product reviews
|
.png "ACE2/HEK293 Stable Cell Line")
